ToolGen Incorporated
KOSDAQTotal Valuation
ToolGen Incorporated carries a market capitalization of 317.53B, placing it among publicly traded companies globally. Its enterprise value stands at 444.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 317.53B |
| Enterprise Value | 444.02B |
Share Statistics
ToolGen Incorporated currently has 8.99M shares outstanding.
| Shares Outstanding | 8.99M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
ToolGen Incorporated trades at a trailing price-to-earnings ratio of 62.79. The price-to-sales ratio is 298.76, and the price-to-book ratio stands at -2.82.
| PE Ratio | 62.79 |
| PS Ratio | 298.76 |
| PB Ratio | -2.82 |
| P/TBV Ratio | 9.12 |
| P/FCF Ratio | -24.28 |
| P/OCF Ratio | -22.49 |
Enterprise Valuation
| EV / Sales | 283.17 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
ToolGen Incorporated maintains a current ratio of 10.94, meaning it holds 10.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.36, indicating conservative leverage, while an interest coverage ratio of -29.84 demonstrates limited ability to service its debt obligations.
| Current Ratio | 10.94 |
| Quick Ratio | 10.45 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -29.84 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -57.07 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.36 |
Stock Price Statistics
ToolGen Incorporated's stock has gained approximately 20.89041% over the past 52 weeks. The 50-day moving average sits at 69,384.00, while the 200-day moving average is 59,942.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 20.89041% |
| 50-Day Moving Average | 69,384.00 |
| 200-Day Moving Average | 59,942.50 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, ToolGen Incorporated generated 1.57B in revenue and converted that into -36.73B in net income, yielding earnings per share of -4,218.66. EBITDA reached -23.26B, while operating income came in at -23.26B.
| Revenue | 1.57B |
| Gross Profit | 1.40B |
| Operating Income | -23.26B |
| Pretax Income | -36.73B |
| Net Income | -36.73B |
| EBITDA | -23.26B |
| EBIT | -23.26B |
| Earnings Per Share (EPS) | -4,218.66 |
Balance Sheet
ToolGen Incorporated holds 24.63B in cash and equivalents against 189.23M in total debt, resulting in a net debt position of -5.70B. Total book value stands at -166.01B, with working capital of 23.43B providing operational flexibility.
| Cash & Cash Equivalents | 24.63B |
| Total Debt | 189.23M |
| Net Debt | -5.70B |
| Equity (Book Value) | -166.01B |
| Book Value Per Share | -19,065.35 |
| Working Capital | 23.43B |
Cash Flow
ToolGen Incorporated produced -20.83B in operating cash flow over the past twelve months. After subtracting -1.53B in capital expenditures, free cash flow totaled -22.36B - equivalent to -2,567.67 per share.
| Operating Cash Flow | -20.83B |
| Capital Expenditures | -1.53B |
| Free Cash Flow | -22.36B |
| FCF Per Share | -2,567.67 |
Margins
ToolGen Incorporated operates with a gross margin of 89.44, reflecting its pricing power and cost economics. The operating margin of -1,483.67 and net profit margin of -2,342.67 provide insight into operational efficiency.
| Gross Margin | 89.44 |
| Operating Margin | -1,483.67 |
| Pretax Margin | -2,342.67 |
| Profit Margin | -2,342.67 |
| EBITDA Margin | -1,483.67 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.22 |
| FCF Yield | -4.12 |
Scores
ToolGen Incorporated posts an Altman Z-Score of 63.18, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 63.18 |